T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Roanne Keeton,Marius B. Tincho,Amkele Ngomti,Richard Baguma,Ntombi Benede,Akiko Suzuki,Khadija Khan,Sandile Cele,Mallory Bernstein,Farina Karim,Sharon V. Madzorera,Thandeka Moyo-Gwete,Mathilda Mennen,Sango Skelem,Marguerite Adriaanse,Daniel Mutithu,Olukayode Aremu,Cari Stek,Elsa du Bruyn,Mieke A. Van Der Mescht,Zelda de Beer,Talita R. de Villiers,Annie Bodenstein,Gretha van den Berg,Adriano Mendes,Amy Strydom,Marietjie Venter,Jennifer Giandhari,Yeshnee Naidoo,Sureshnee Pillay,Houriiyah Tegally,Alba Grifoni,Daniela Weiskopf,Alessandro Sette,Robert J. Wilkinson,Tulio de Oliveira,Linda-Gail Bekker,Glenda Gray,Veronica Ueckermann,Theresa Rossouw,Michael T. Boswell,Jinal N. Bhiman,Penny L. Moore,Alex Sigal,Ntobeko A. B. Ntusi,Wendy A. Burgers,Catherine Riou

DOI: https://doi.org/10.1038/s41586-022-04460-3

IF: 64.8

2022-01-31

Nature

Abstract:Abstract The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1,2 that contribute to viral escape from antibody neutralization 3–6 and reduce vaccine protection from infection 7,8 . The extent to which other components of the adaptive response such as T cells may still target Omicron and contribute to protection from severe outcomes is unknown. Here we assessed the ability of T cells to react to Omicron spike protein in participants who were vaccinated with Ad26.CoV2.S or BNT162b2, or unvaccinated convalescent COVID-19 patients ( n = 70). Between 70% and 80% of the CD4 + and CD8 + T cell response to spike was maintained across study groups. Moreover, the magnitude of Omicron cross-reactive T cells was similar for Beta (B.1.351) and Delta (B.1.617.2) variants, despite Omicron harbouring considerably more mutations. In patients who were hospitalized with Omicron infections ( n = 19), there were comparable T cell responses to ancestral spike, nucleocapsid and membrane proteins to those in patients hospitalized in previous waves dominated by the ancestral, Beta or Delta variants ( n = 49). Thus, despite extensive mutations and reduced susceptibility to neutralizing antibodies of Omicron, the majority of T cell responses induced by vaccination or infection cross-recognize the variant. It remains to be determined whether well-preserved T cell immunity to Omicron contributes to protection from severe COVID-19 and is linked to early clinical observations from South Africa and elsewhere 9–12 .

multidisciplinary sciences